Literature DB >> 30309700

Injection of Saline Into the Biopsy Tract and Rapid Patient Rollover Decreases Pneumothorax Size Following Computed Tomography-Guided Transthoracic Needle Biopsy.

Eugenia Khorochkov1, Gregory J Garvin2, Stefan Potoczny2, Roman I Kozak2.   

Abstract

PURPOSE: To determine if saline tract injection and rapid patient rollover following computed tomography (CT)-guided transthoracic needle biopsy (TTNB) affects pneumothorax incidence and size.
METHODS: A retrospective cohort design was used to compare 278 patients who underwent post-biopsy saline injection and rapid rollover so that the biopsy site was dependent (N = 180) to a control group with routine post-biopsy care (N = 98). Post-procedure radiographs and CT were assessed for presence and size of pneumothorax, as well as requirement for chest tube placement.
RESULTS: Pneumothorax size as estimated on post-procedure CT was 3.33% in the treatment group and 6.63% in the control group (P < .05). There was also a reduction in chest tube placements in the treatment group (3.9% vs 10%, P < .05). On post-procedure radiographs, pneumothorax rates were 20% in the treatment group, and 25% in the control group (P > .05).
CONCLUSION: Saline injection with rapid patient rollover following TTNB significantly decreased pneumothorax size and chest tube placement but not incidence.
Copyright © 2018 Canadian Association of Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Lung biopsy; Patient rollover; Pneumothorax reduction; Saline injection

Mesh:

Substances:

Year:  2018        PMID: 30309700     DOI: 10.1016/j.carj.2018.08.002

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  1 in total

1.  Effect of puncture sites on pneumothorax after lung CT-guided biopsy.

Authors:  Li-Chuan Zeng; Hua-Qiang Liao; Wen-Bin Wu; Yu-Dong Zhang; Feng-Chun Ren; Qu Wang; Ming-Guo Xie
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.